Tesamorelin & Ipamorelin (10mg:5mg) Stack – GHRH & Ghrelin Receptor Synergism in Pulsatile GH Secretion Research

Description

What is Tesa 10mg + Ipa 5mg & Research Background?

The Tesa 10mg + Ipa 5mg blend is a sophisticated dual-peptide formulation consisting of Tesamorelin and Ipamorelin. Tesamorelin is a stabilized Growth Hormone-Releasing Hormone (GHRH) analogue, while Ipamorelin is a selective Growth Hormone Secretagogue (GHS) and ghrelin receptor agonist. This specific ratio is engineered for laboratory studies investigating the amplified secretion of endogenous growth hormone through two distinct physiological pathways.

At 99Purity-Peptide, we provide this combination as a high-purity, vacuum-sealed lyophilized powder. By blending these two compounds into a single vial, researchers can study the potentiation effect—where the GHRH and GHRP components work in tandem to optimize somatotroph signaling and targeted adipose tissue metabolism.

Tesa 10mg + Ipa 5mg Mechanism of Action and Research

The primary mechanism of the Tesa / Ipa blend involves a two-pronged approach to Growth Hormone (GH) regulation. Tesamorelin acts on the pituitary gland to stimulate the production and release of endogenous GH by mimicking the natural GHRH signal. Concurrently, Ipamorelin acts as a Growth Hormone Releasing Peptide (GHRP), which not only stimulates GH release but also inhibits somatostatin—the hormone responsible for stopping GH production. This synergy results in a more robust and sustained GH pulse compared to either peptide used in isolation.

In metabolic research, this blend is frequently studied for its impact on visceral adipose tissue (VAT) and its potential to improve lipid profiles without significantly affecting glucose sensitivity. The structural integrity of the peptides in this lyophilized format allows for precise dosing in longitudinal studies focusing on body composition and cellular regeneration.

Trending Research Topics & High-Authority Insights:

• GHRH and GHRP Synergistic Signaling: Investigating the “pulse” optimization in pituitary research.

• Reduction of Visceral Fat in Metabolic Models: The role of Tesamorelin-based blends in lipid regulation.

• Tesamorelin and pituitary hormone regulation – ScienceDirect

Tesa 10mg + Ipa 5mg Specifications

Feature	Specification
Product Name	Tesa 10mg + Ipa 5mg Blend
Available Strengths	Tesamorelin 10mg + Ipamorelin 5mg
Physical Appearance	White Lyophilized Powder
Purity	≥ 99% (HPLC/MS Verified)
Molecular Formula	$C_{221}H_{366}N_{72}O_{67}S_{1}$ (Tesa) / $C_{38}H_{49}N_{9}O_{5}$ (Ipa)
Molecular Weight	5135.9 g/mol / 711.9 g/mol
CAS Number	218949-48-5 (Tesa) / 170851-70-4 (Ipa)
Verification	3rd-Party Lab Tested with COA
Storage Instructions	Store at -20°C (Long-term); 2-8°C after reconstitution

Tesa 10mg + Ipa 5mg Key Features & Benefits

• Advanced Dual-Peptide Formula: Combines a GHRH analogue and a GHRP agonist for maximum synergistic research outcomes.

• Targeted Metabolic Studies: Specifically relevant to research involving visceral fat reduction and energy expenditure.

• Ultra-High Purity Preparations: Synthesized at 99%+ purity to eliminate experimental noise and ensure reproducible data.

• Sterile Freeze-Dried Format: Provided as a vacuum-sealed lyophilized powder for superior chemical stability and extended shelf life.

• Independently Verified Identity: Each batch is confirmed via HPLC and Mass Spectrometry to guarantee exact peptide ratios and purity.

Tesa 10mg + Ipa 5mg FAQ

What is the advantage of blending Tesamorelin and Ipamorelin?

In research, Tesamorelin provides the signal for GH release, while Ipamorelin amplifies that signal and suppresses somatostatin. This “push-pull” dynamic is studied for its ability to produce a more natural and efficient growth hormone pulse than single-agent protocols.

Why is the 10mg/5mg ratio commonly used in research?

This specific ratio is often utilized to balance the potent GHRH stimulation of Tesamorelin with the highly selective GHRP action of Ipamorelin, providing a stable baseline for metabolic and body composition studies.

How should the Tesa/Ipa blend be handled in the lab?

The lyophilized powder should be kept at -20°C for long-term storage. When ready for use, it is typically reconstituted with bacteriostatic water. Due to the sensitivity of the peptide bonds, the vial should be swirled gently rather than shaken.

Are there Certificate of Analysis (COA) documents available?

Yes. 99Purity-Peptide provides full 3rd-party testing documentation for every batch of the Tesa 10mg + Ipa 5mg blend, ensuring the purity meets scientific requirements.

Why Buy Tesa 10mg + Ipa 5mg online from 99Purity-Peptide?

• Precision Blending Consistency: We ensure that every 10mg/5mg vial contains the exact ratio of peptides specified, allowing for consistent and reliable research data across multiple studies.

• Discreet Global Logistics: We prioritize your research privacy. All orders are dispatched in secure, unbranded packaging with expedited, tracked shipping to the USA, UK, and Europe.

• Professional Grade Reliability: As a specialized biotech supplier, we offer 1-2 business day dispatch and maintain high stock levels for critical research timelines.

• Verified Quality Assurance: Every purchase is backed by HPLC/MS verification, guaranteeing that you receive high-purity, laboratory-grade research materials every time.

Payment Support & Logistics

• Secure Payment Options: We support multiple secure gateways, including Credit Cards, Cryptocurrency (USDT, USDC), PayPal, and Bank Transfers.

• Global Shipping: Fast, tracked delivery available to the United States, United Kingdom, and Europe.

• Processing Time: All orders are professionally handled and dispatched within 1-2 business days after payment confirmation.

Regulatory Disclaimer

99Purity-Peptide is a chemical supplier. We are not a compounding pharmacy or an outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). All products are strictly for research, laboratory, or analytical use only and are NOT for human consumption.

References & Academic Links

• Spooner, R. K., et al. (2012). “Tesamorelin: a growth hormone-releasing hormone analogue.” Drug Design, Development and Therapy.

• Raun, K., et al. (1998). “Ipamorelin, the first selective growth hormone secretagogue.” European Journal of Endocrinology.